-
Arbor Pharma Announces Acquisition Of Xenoport At A 60% Premium
Monday, May 23, 2016 - 9:26am | 339Read More...Shares of XenoPort, Inc. (NASDAQ: XNPT), a small-cap bio-pharmaceutical company that focuses on the commercializing HORIZANT in the United States for the treatment of adults with moderate to severe primary Restless Legs Syndrome, surged higher by nearly 60 percent early Monday morning. XenoPort...
-
Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks
Tuesday, January 20, 2015 - 2:00pm | 440Read More...Over the past week, analysts at Jefferies have been holding meetings with senior executives from 29 specialty pharmaceutical (21 branded, eight generic) companies. Following the discussions, here are the main takeaways. Following its busiest year ever for acquisitions, the industry will...
